1) standardized house-dust mite
标准化屋尘螨
1.
Objective To explore the tolerance and compliance during the phase of specific immunotherapy with standardized house-dust mite extract in asthmatic children.
方法对无锡市儿童医院哮喘专科临床诊断为哮喘51例患儿,应用标准化屋尘螨提取液皮下注射,进行特异性免疫治疗33周,观察剂量递增阶段和维持阶段每次免疫注射后速发和迟发不良反应发生情况,在每次变应原注射前和注射后30 m in测其呼吸峰流速值(PEF),总结不良反应事件发生的原因,分析患儿对治疗的依从性。
3) standardized mites allergens
标准化屋尘螨变应原制剂
1.
AIM: To observe the clinical effects, lung function, and adverse reactions of standardized mites allergens immunotherapy for allergic asthmatic children.
目的:观察标准化屋尘螨变应原制剂治疗儿童变应性哮喘前后的临床疗效、肺功能与不良反应。
4) standard allergen vaccine
标准化粉尘螨疫苗
5) Dermatophagoides pteronyssinus
屋尘螨
1.
Purification and Immunogenicity Analysis of the Recombinant Allergen Der p 1 from Dermatophagoides pteronyssinus;
屋尘螨变应原Der p 1基因原核表达产物的纯化及特性鉴定
2.
Antigenic localization of Der p1 in the body of the house dust mite, Dermatophagoides pteronyssinus by immunohistochemistry;
屋尘螨Ⅰ类变应原Der p1的体内定位
6) house dust mite
屋尘螨
1.
Enhanced release of cytokines from peripheral eosinophils activated by house dust mite allergen Der p1;
屋尘螨1类变应原促进外周血嗜酸性粒细胞释放细胞因子的探讨
2.
Comparative study of allergic pulmonary inflammation of BALB/c and C57BL/6 mice sensitized and challenged with house dust mite extracts;
屋尘螨提取液致敏BALB/c与C57BL/6小鼠肺部变应性炎症模型的比较
3.
Objective:To evaluate the clinical effect of specific immunotherapy(SIT) with standardized house dust mite vaccine on chronic urticaria.
结果:SIT后大多数患者自觉症状明显改善,血清屋尘螨sIgE抗体明显降低。
补充资料：欧洲标准化委员会标准(见欧洲标准化委员会)
欧洲标准化委员会标准(见欧洲标准化委员会)
standards of CEN: see European Committee for Standardization; CEN
Ouzhou BiaozhunhuaW白}和。nhui biaoZhun欧洲标准化委员会标准(stand田月5 of CEN)见欧洲标准化委员会。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条